Cordlife Group (SGX:P8A), a cord blood banking company, has been directed by the Ministry of Health (MOH) to comply with new operational restrictions starting Sept. 15, according to a Friday filing on the Singapore Exchange.
Under the Third Notice issued by the MOH, the company must limit its cord blood collection, testing, processing, and storage to 30 units per month until Jan. 13, 2025.
The company has confirmed it will adhere to these restrictions, which will impact its operations and are expected to negatively affect its financial performance for the fiscal year ending Dec. 31, 2024.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。